Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter

Vaccine

Volumn 20, Issue 27-28, 2002, Pages 3322-3331

  Cazeaux, Nicolas ^a   Bennasser, Yamina ^a   Vidal, Pierre Louis ^a   Li, Zhenlin ^b   Paulin, Denise ^b   Bahraoui, Elmostafa ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

DNA vaccines; HIV 1; Muscle specific desmin promoter; Nef

Indexed keywords

ANTIGEN; CYTOKINE; DESMIN; DNA VACCINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; NEF PROTEIN; PROTEIN ANTIBODY; VIRUS DNA;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOSE RESPONSE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; MUSCLE CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL;

AIDS VACCINES; ANIMALS; ANTIBODY SPECIFICITY; CELL LINE; CYTOKINES; CYTOMEGALOVIRUS; DESMIN; FEMALE; GENE PRODUCTS, NEF; GENES, NEF; HIV ANTIBODIES; HIV-1; HUMANS; IMMUNIZATION; KINETICS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MUSCLES; PLASMIDS; PROMOTER REGIONS (GENETICS); TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 0037056040     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00310-9     Document Type: Article

References (37)

1. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes J.H., Felgner P.L., Dwarki V.J.et al. Heterologous protection against influenza by injection of DNA encoding viral protein. Science. 259:1993;1745-1749.
2. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11478-11482.
3. Cox G., Zamb T.J., Babiuk L.A. Bovine herpes virus-I-immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:1993;5664-5667.
4. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabbies virus. Virology. 199:1994;132-140.
5. Prince A.M., Whalen R., Brotman B. Successful DNA-based HBV DNA immunization of newborn chimpanzees. Vaccine. 15:1996;916-919.
6. Robinson H.L., Montefiori D.C., Johnson R.P., Manson H.K., Kalish M.L., Lifson J.D.et al. Neutralizing antibody-independent containment of immunodeficiency virus challenge by DNA priming and recombinant poxvirus boosters immunizations. Nat. Med. 5(5):1999;526-534.
7. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Guilbert L., Bagarazzi M.et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3:1997;526-532.
8. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y.et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90(9):1993;4156-4160.
9. Ulmer J.B., Deck R.R., Dewitt C.M., Donnely J.I., Liu M.A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells. Immunology 89:1996;59-67.
10. Ulmer J.B., Deck R.R., Dewitt C.M., Donnely J.I., Liu M.A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology. 89:1996;59-67 Ulmer J.B. Generated immune responses against human immunodeficiency virus type 1s. Proc. Natl. Acad. Sci. USA. 90:1996;4156-4160.
11. Dupuis M., Denis-Mize K., Woo C., Goldbeck C., Selby M.J., Chen M.et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J. Immunol. 165:2000;2850-2858.
12. Furth P.A., St. Onge L., Boger H., Gruss P., Gossen M., Kistner A.et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci. USA. 91(20):1994;9302-9306.
13. Qin L., Ding Y., Pahud D.R., Chang E., Imperiale M.J., Bromberg J.S. Promoter attenuation in gene therapy: interferon gamma and tumor necrosis factor alpha inhibit transgene expression. Hum. Gene Ther. 8:1997;2009-2010.
14. Li Z., Marchand P., Humbert J., Babinet C., Paulin D. Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development. 117:1993;947-959.
15. Cohen J. Glimmerings of hope from the bottom of the well. Science. 285:1999;656-657.
16. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998;102(9):1758-65.
17. Cheynier R., Langlade-Demoyen P., Marescot M.R., Blanche S., Blondin G., Wain-Hobson S.et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:1992;2211-2217.
18. Fujii Y, Nishino Y, Nakaya T, Tokunaga K, Ikuta K. Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells. Vaccine 1993;11:1240-6.
19. + cells. J. Immunol. 153:1994;5826-5837.
20. Moynier M., Kavsan V., Galés C., Montagnier L., Bahraoui E. Characterization of humoral immune response induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein. Vaccine. 16:1998;1523-1530.
21. Sabatier J.M., Clerget-Raslain B., Fontan G., Fenouillet E., Rochat H., Granier C.et al. Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients. AIDS. 4:1990;215-220.
22. Guéry J.-C., Galbiati F., Smirolodo S., Adorini L. Selective development of T-helper (Th2) cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient mice. J. Exp. Med. 183:1996;485-497.
23. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A.et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
24. Hasan U.A., Abai A.M., Harper D.R., Wren B.W., Morrow W.J.W. Nucleic acid immunization: concepts and techniques associated with third generation vaccines. J. Immunol. Methods. 229:1999;1-22.
25. Tang D.C., Devitt M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
26. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y.et al. Induction of antigen-specific T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476-480.
27. Donnelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW, Motzel SL, Ulmer JB, Liu MA. Pre-clinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1995;6:583-7.
28. Anderson R., Gao X.-M., Papakonsantinopoulou A., Roberts M., Dougan G. Immune response in BALB/c mice following intramuscular immunization with DNA encoding fragment C of tetanus toxoid. Infect. Immun. 64:1996;3168-3173.
29. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci. USA. 91(21):1994;9866-9870.
30. Davis H.L., Mancini M., Michel M.L., Whalen R.G. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine. 14:1996;910-915.
31. Finkelman F.D., Holmes J., Katona I.M., Urban J.F. Jr., Beckmann M.P., Park L.S.et al. Lymphokine control of in vivo immunoglobulin isotype secretion. Ann. Rev. Immunol. 8:1990;303-333.
32. + Nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1:1995;1167-1173.
33. Loirat D., Li Z., Mancini M., Tiollais P., Paulin D., Michel M.-L. Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology. 260:1999;74-83.
34. Klinman D., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:1997;3635-3639.
35. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.-N.et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
36. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1996;1122-1128.
37. Chattergoon M.A., Robinson T.M., Boyer J.D., Weiner D.B. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophage/antigen presenting cells. J. Immunol. 160:1998;5707-5718.